In a December 2017 letter to NIH, Duke highlighted concerns of research misconduct by leaders in its psychology department. Misconduct allegations included not following research plans, not reporting adverse events to the Institutional Review Board, and signing data forms without conducting assessments, according to a letter NIH sent Duke in March 2018.
NIH suspended Duke’s grants that month after the university failed to address the agency’s “overarching concern for the welfare and safety of research participants as well as several pertinent questions concerning the reported research irregularities,” NIH wrote in the letter cited by Medscape.
NIH and Duke did not disclose which grants or investigators were involved in the allegations. A spokesperson for Duke told Medscape that the grants are no longer suspended.
More articles on clinical leadership and infection control:
New York driving surge in measles cases: 4 things to know
Better patient experience, employee engagement can boost hospital finances
Health officials investigate Illinois hospital treating baby cut from woman’s womb
